Lupin Has Appointed Abdelaziz Toumi as CEO of Manufacturing ArmÂ
Pharmaceutical major Lupin Limited plans to increase its contract manufacturing business for its international clients and has appointed a new CEO. They have appointed Abdelaziz...
Tag : Lupin
Lupin Shares 7% as Q4 Earnings Failed to Impress InvestorsÂ
Shares of Lupin crashed 7% on 7 May after the company announced its quarterly earnings for January-March. The drug maker reported a 52% year-on-year increase in...
Lupin Shares Gain 2% on Launching Doxycycline Capsules in US
Shares of Lupin Ltd were trading in the green and 2% higher on 10 April after the company announced launching its first generic version of...
Lupin Gets USFDA Approval for Drug for Gout, Stock Hits Nearly 7-Year High Levels
Lupin’s shares hit a fresh yearly high on January 19 after the pharma company received approval from the United States Food and Drug Administration (US...
Lupin Shares Gain 2% USFDA Approval for Hypertension Drug
Shares of Lupin were trading in the green and 2% higher on 15 January after the company announced receiving approval from the USFDA to market...
Lupin Shares Gain 1% on Launching Cataract Surgery Pain Reduction Drug
Shares of Lupin were trading in the green and 1% higher on 10 January after the company announced the launch of a cataract surgery pain...
Lupin Shares Hit 52-Week High on Receiving USFDA Approval
Shares of Lupin hit a 52-week high of Rs 1,345.75 on 28 December after the company received approval from the USFDA (US Food and Drug...
Lupin Acquired Portfolio of Drugs in Europe and Canada
Pharmaceutical major Lupin Ltd, on 22 December, announced that it has acquired a portfolio of established products in Europe and Canada for a total consideration...
Lupin Shares Gain 3% on Receiving Approval From USFDA for Gout and Diabetes Drugs
Shares of Lupin were trading in the green and 3% higher on 18 December after the company announced receiving approval from the USFDA (US Food...
Lupin Shares Surge After Receiving Back-to-back USFDA approvals
Shares of Lupin experienced a 3% surge during early trading on November 24, a day after it disclosed tentative approval from the United States Food...